These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 16012126)

  • 1. Development of the allocation system for deceased donor liver transplantation.
    Coombes JM; Trotter JF
    Clin Med Res; 2005 May; 3(2):87-92. PubMed ID: 16012126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant benefit-based offering of deceased donor livers in the United Kingdom.
    Allen E; Taylor R; Gimson A; Thorburn D
    J Hepatol; 2024 Sep; 81(3):471-478. PubMed ID: 38521169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation in the MELD era: a single-center experience.
    Sachdev M; Hernandez JL; Sharma P; Douglas DD; Byrne T; Harrison ME; Mulligan D; Moss A; Reddy K; Vargas HE; Rakela J; Balan V
    Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
    Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
    Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
    Bowring MG; Zhou S; Chow EKH; Massie AB; Segev DL; Gentry SE
    Transplantation; 2019 Oct; 103(10):2113-2120. PubMed ID: 30801545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy.
    Wiesner RH; Freeman RB; Mulligan DC
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S261-7. PubMed ID: 15508092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history of organ donation and transplantation in Iran.
    Ghods AJ
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():38-41. PubMed ID: 24635790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Disparity in Liver Transplant and Access to Living Donation.
    Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
    JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation.
    Sharma P; Harper AM; Hernandez JL; Heffron T; Mulligan DC; Wiesner RH; Balan V
    Am J Transplant; 2006 Aug; 6(8):1957-62. PubMed ID: 16771808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
    Ahmad J; Bryce CL; Cacciarelli T; Roberts MS
    Ann Intern Med; 2007 May; 146(10):707-13. PubMed ID: 17502631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.